Craze Mark, Young Melodie
Texas Dermatology Associates, 5310 Harvest Hill, Suite 260, Dallas, TX 75230, USA.
J Am Acad Dermatol. 2003 Aug;49(2 Suppl):S139-42. doi: 10.1016/mjd.2003.558.
This article discusses the issues involved in the integration of biologic therapies for psoriasis into a dermatology practice. The requirements for staff, space, and other office adaptations are reviewed for infliximab, efalizumab, etanercept, and alefacept in their current injectable forms. Dermatologists will likely elect to offer some or all of these therapies depending on the adjustments necessary within their current practice, patient satisfaction, and the economic possibilities. This article provides information needed to guide dermatology practices in practical decisions regarding the use of biologic therapies.
本文讨论了将银屑病生物疗法纳入皮肤科临床实践所涉及的问题。针对英夫利昔单抗、依法利珠单抗、依那西普和阿法赛特目前的注射剂型，对人员、空间及其他办公室调整方面的要求进行了综述。皮肤科医生可能会根据其当前临床实践中所需的调整、患者满意度以及经济可能性，选择提供部分或全部这些疗法。本文提供了相关信息，以指导皮肤科临床实践在使用生物疗法方面做出实际决策。
